Synformulas GmbH

About Synformulas GmbH

We are a leading global probiotics company focusing on smart bacteria for treating patients with allergies and gastrointestinal diseases. We have achieved a breakthrough in the treatment of irritable bowel syndrome:

In two independent studies, our patented bacterial strain MIMBb75 displayed a significant effect with regard to the...

  • DE
  • 2021
    On CPHI since
  • 3
  • 100 - 249
Company types
Contact info

Products from Synformulas GmbH (3)

  • Kijimea® IBS PRO

    Product Kijimea® IBS PRO

    Kijimea® IBS PRO is the development of the medical device Kijimea® IBS. With the patch effect of the heat-inactivated bifidobacterial strain B. bifidum HI-MIMBb75, Kijimea® IBS PRO combats all intestinal complaints of IBS such as diarrhoea, abdominal pain, flatulence, or constipation even more effectiv...
  • Kijimea® K53

    Product Kijimea® K53

    Kijimea® K53 is a dietary supplement containing 53 selected microculture strains found in the natural intestinal flora of humans. One pack of Kijimea K53 contains 1 trillion microcultures. In addition, Kijimea® K53 contains vitamin B12, which helps to reduce fatigue and tiredness and to promote normal...
  • Kijimea® Regularis

    Product Kijimea® Regularis

    Kijimea® Regularis contains the unique Synformularis2 fibre complex. Thanks to its special structure, it is activated by water within a few seconds, but only swells in the intestine.

    This gently stretches the intestinal muscles. It receives an impulse to move normally again. The food in...

Synformulas GmbH Resources (1)